Orchid Biosciences, Inc. - ORCH- Profile

Orchid BioSciences, Inc.. The Group's principal activities are to develop and commercialize genetic diversity technologies, products and services for genetic biochemistry applications. The Group's genetic diversity products, scoring single nucleotide polymorphisms and microfluidics technologies are used in drug discovery, principally in the field of pharmacogenetics and DNA synthesis. Genetic diversity information is used by the pharmaceutical and medical communities to facilitate the development of highly specific and efficacious drugs, to improve the effectiveness of existing drugs and to increase the likelihood of success of tissue transplants. The Group's proprietary technologies are also used in other commercial applications outside the healthcare field including forensics, paternity testing, improved crop development and livestock breeding programs. Identity genomics accounted for 78% of 2002 revenues; Life sciences, 22%, & Other, nominal.